# ArriVent BioPharma, Inc. Common Stock (AVBP.US)

Canonical: https://gigainvestors.com/s/AVBP

Analysis as of: 2026-10-16T07:26:41.037Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $16.79 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

## Price story

Down 52% since Jun 2026

Story as of 2026-10-16T10:01:29.449Z; price observation 2026-10-15.

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### Where the cash goes

Paid no dividends in 2 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-05); Dividend observations: [[2024,0],[2025,0]]. Zero only counted when supported by a complete cash-flow statement.

### Are managers owners

Insiders own 1.5% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-15); AVBP.US SharesStats.PercentInsiders = 1.543 percentage points; cache date 2026-10-15.

### What the price says

The price is 2.1 times net assets; cash earnings are negative.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-05); Closing price 16.79 USD; reporting-to-trading FX 1; FY2025 net assets per share 7.987603542142237; price multiple 2.1020071804286125. FY2025 cash earnings/share -4.402562489275296. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2024-01: $21.55 per share

- 2024-02: $21.54 per share

- 2024-03: $17.86 per share

- 2024-04: $16.52 per share

- 2024-05: $19.41 per share

- 2024-06: $18.55 per share

- 2024-07: $21.90 per share

- 2024-08: $26.73 per share

- 2024-09: $23.50 per share

- 2024-10: $29.34 per share

- 2024-11: $29.96 per share

- 2024-12: $26.64 per share

- 2025-01: $28.54 per share

- 2025-02: $23.61 per share

- 2025-03: $18.49 per share

- 2025-04: $21.26 per share

- 2025-05: $21.25 per share

- 2025-06: $21.77 per share

- 2025-07: $19.51 per share

- 2025-08: $19.12 per share

- 2025-09: $18.45 per share

- 2025-10: $18.73 per share

- 2025-11: $22.94 per share

- 2025-12: $20.12 per share

- 2026-01: $22.49 per share

- 2026-02: $22.97 per share

- 2026-03: $23.07 per share

- 2026-04: $31.09 per share

- 2026-05: $30.27 per share

- 2026-06: $34.74 per share

- 2026-07: $29.82 per share

- 2026-08: $30.05 per share

- 2026-09: $30.28 per share

- 2026-10: $16.79 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1868279/000110465926024127/avbp-20251231x10k.htm); period 2025-12-31, filed 2026-03-05.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations



# AVBP — Arrivent Biopharma Inc

Held by 1 investor · USD 7,772,579 total · 2025 Q3 · reported price USD 18.45 (split-adjusted).
Page: https://gigainvestors.com/s/AVBP

## Holders (2025 Q3)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| Leon Cooperman (https://gigainvestors.com/oa) | USD 7,772,579 | 0.2% | hold |

## Total held by quarter

- 2025 Q2: USD 9,171,222 · 1 holder · USD 21.77
- 2025 Q3: USD 7,772,579 · 1 holder · USD 18.45
- 2025 Q4: USD 0 · 0 holders